A novel vaccine targeting Fusobacterium nucleatum against abscesses and halitosis.
暂无分享,去创建一个
[1] L. Kocgozlu,et al. Prevalence of periodontal pathogens in subgingival lesions, atherosclerotic plaques and healthy blood vessels: a preliminary study. , 2008, Journal of periodontal research.
[2] K. Okuda,et al. Stimulation of Fusobacterium nucleatum biofilm formation by Porphyromonas gingivalis. , 2007, Oral microbiology and immunology.
[3] B. Karthikeyan,et al. Vaccination against periodontitis: the saga continues , 2007, Expert review of vaccines.
[4] P. Moore,et al. Hydrogen sulfide induces the synthesis of proinflammatory cytokines in human monocyte cell line U937 via the ERK‐NF‐κB pathway , 2007, Journal of leukocyte biology.
[5] D. Tang,et al. Topical Application of Escherichia coli-Vectored Vaccine as a Simple Method for Eliciting Protective Immunity , 2006, Infection and Immunity.
[6] Hyun-chul Lee,et al. Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds. , 2006, Journal of clinical periodontology.
[7] M. Tufano,et al. Neutrophil function in rapidly progressive and adult periodontitis , 2006, European Journal of Epidemiology.
[8] Jumpei Washio,et al. Hydrogen sulfide-producing bacteria in tongue biofilm and their relationship with oral malodour. , 2005, Journal of medical microbiology.
[9] J. Hearst,et al. Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity , 2005, Nature Medicine.
[10] E. Weiss,et al. Fluorescence based measurements of Fusobacterium nucleatum coaggregation and of fusobacterial attachment to mammalian cells. , 2005, FEMS microbiology letters.
[11] G. Seymour,et al. Modulation of the antibody response by Porphyromonas gingivalis and Fusobacterium nucleatum in a mouse model. , 2004, Oral microbiology and immunology.
[12] Yiping W Han,et al. Fusobacterium nucleatum Induces Premature and Term Stillbirths in Pregnant Mice: Implication of Oral Bacteria in Preterm Birth , 2004, Infection and Immunity.
[13] J. Liebana,et al. Periodontal diseases: microbiological considerations. , 2004, Medicina oral, patologia oral y cirugia bucal.
[14] Armando Garcia,et al. Minibioreactor-gas collector for determining bacteria-produced hydrogen sulfide , 2003 .
[15] D. Hinode,et al. Relationship between tongue coating and secretory-immunoglobulin A level in saliva obtained from patients complaining of oral malodor. , 2003, Journal of clinical periodontology.
[16] Modelling oral malodour in a longitudinal study. , 2003, Archives of oral biology.
[17] Y. Kawamura,et al. Use of micro gas chromatography in the fuel cycle of fusion reactors , 2003 .
[18] J. Nicoli,et al. Cytokine production in response to endodontic infection in germ-free mice. , 2002, Oral microbiology and immunology.
[19] Robert J. Palmer,et al. Communication among Oral Bacteria , 2002, Microbiology and Molecular Biology Reviews.
[20] H. Fukamachi,et al. 3‐Chloro‐DL‐alanine resistance by L‐methionine‐α‐deamino‐γ‐mercaptomethane‐lyase activity , 2002 .
[21] D J Smith,et al. Dental caries vaccines: prospects and concerns. , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[22] J. Mcghee,et al. A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants. , 2002, Vaccine.
[23] Y. Shimazaki,et al. Immunization against dental caries. , 2002, Vaccine.
[24] G. Seymour,et al. Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model , 2002, Clinical and experimental immunology.
[25] H. Fukamachi,et al. 3-Chloro-DL-alanine resistance by L-methionine-alpha-deamino-gamma-mercaptomethane-lyase activity. , 2002, FEBS letters.
[26] M. A. Borrello,et al. Prior exposure of mice to Fusobacterium nucleatum modulates host response to Porphyromonas gingivalis. , 2000, Oral microbiology and immunology.
[27] G L Roberts,et al. Fusobacterial infections: an underestimated threat. , 2000, British journal of biomedical science.
[28] C. Desloovere,et al. [Halitosis--foetor ex ore]. , 1998, Laryngo- rhino- otologie.
[29] J. Holmgren,et al. Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine. , 1998, Vaccine.
[30] S. Wåler,et al. On the transformation of sulfur-containing amino acids and peptides to volatile sulfur compounds (VSC) in the human mouth. , 1997, European journal of oral sciences.
[31] B. Shenker,et al. Fusobacterium nucleatum inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle , 1995, Infection and immunity.
[32] K. Yaegaki,et al. Volatile sulfur compounds in mouth air from clinically healthy subjects and patients with periodontal disease. , 1992, Journal of periodontal research.
[33] J. P. Smith,et al. Accumulation of plasma cells in inflamed sites: effects of antigen, nonspecific microbial activators, and chronic inflammation , 1991, Infection and immunity.
[34] T. Hofstad,et al. Outer membrane proteins as major antigens of Fusobacterium nucleatum. , 1989, FEMS microbiology immunology.
[35] J. Thompson,et al. Amino acid-dependent transport of sugars by Fusobacterium nucleatum ATCC 10953 , 1987, Journal of bacteriology.
[36] H. Yoshie,et al. Effects of a Fusobacterium nucleatum Extract on Immunoregulation in Mice , 1985, Journal of dental research.
[37] K. Okuda,et al. Immunoglobulin G response to subgingival gram-negative bacteria in human subjects , 1984, Infection and immunity.
[38] A. González,et al. [Microbiological aspects of halitosis and its treatment]. , 1983, Revista ADM : organo oficial de la Asociacion Dental Mexicana.
[39] M. Aono,et al. Adjuvant effects of oral microorganisms on the immunological responses. , 1974, Archives of oral biology.
[40] J. Tonzetich. Direct gas chromatographic analysis of sulphur compounds in mouth air in man. , 1971, Archives of oral biology.